ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hedner, J
Right arrow Articles by Caidahl, K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hedner, J
Right arrow Articles by Caidahl, K
Eur Respir J 1995; 8: 222-229
Copyright © ERS Journals Ltd 1995


Original Articles

Reduction in sympathetic activity after long-term CPAP treatment in sleep apnoea: cardiovascular implications

J Hedner, B Darpo, H Ejnell, J Carlson, and K Caidahl

Twelve patients with severe obstructive sleep apnoea were included in an open, long-term, prospective, follow-up study addressing the effects of nasal continuous positive airway pressure (CPAP) on sympathetic activity, cardiac structure and blood pressure. Plasma norepinephrine (P-NE) (daytime at rest), daytime and night-time urinary excretion of NE (U-NE), vanylmandelic acid and metanephrines, together with 24 h noninvasive blood pressure (BP) recording and Doppler-echocardiography, were assessed before and after a mean of 20.5 (range 14-26) months of CPAP. Average self-reported use of CPAP was 89% (range 65-100%) of time spent in bed. Resting daytime P-NE ranged 0.35-0.83 ng.ml-1, which is elevated compared to healthy controls. Only night-time U-NE, mean daytime BP and average 24 h BP were related to severity of OSA. Night-time metanephrine was related to daytime and night-time diastolic, as well as night-time systolic, BP. Left ventricular mass index (LVMI) at baseline was correlated to daytime systolic BP and P-NE. Long-term CPAP treatment reduced biochemical markers of sympathetic activity. P-NE decreased by approximately 50%, and daytime and night-time vanylmandelic acid and metanephrine by 32-54%. In contrast, there were no overall reductions in BP or LVMI. It is concluded that obstructive sleep apnoea is associated with high sympathetic activity both during sleep and waking periods. Urinary metanephrine excretion seemed to reflect blood pressure, but neither daytime nor night-time catecholamine excretion was directly related to disease severity in patients with severe obstructive sleep apnoea.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
Eur Respir JHome page
L. Lavie and P. Lavie
Molecular mechanisms of cardiovascular disease in OSAHS: the oxidative stress link
Eur. Respir. J., June 1, 2009; 33(6): 1467 - 1484.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
M. Kohler, J. C. T. Pepperell, B. Casadei, S. Craig, N. Crosthwaite, J. R. Stradling, and R. J. O. Davies
CPAP and measures of cardiovascular risk in males with OSAS
Eur. Respir. J., December 1, 2008; 32(6): 1488 - 1496.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
G V Robinson, B A Langford, D M Smith, and J R Stradling
Predictors of blood pressure fall with continuous positive airway pressure (CPAP) treatment of obstructive sleep apnoea (OSA)
Thorax, October 1, 2008; 63(10): 855 - 859.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F. Valham, T. Mooe, T. Rabben, H. Stenlund, U. Wiklund, and K. A. Franklin
Increased Risk of Stroke in Patients With Coronary Artery Disease and Sleep Apnea: A 10-Year Follow-Up
Circulation, August 26, 2008; 118(9): 955 - 960.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
S. Andreas and G. Eichele
Sleep apnoea: time to consider clock genes
Eur. Respir. J., July 1, 2008; 32(1): 1 - 2.
[Full Text] [PDF]


Home page
ThoraxHome page
M D Cross, N L Mills, M Al-Abri, R Riha, M Vennelle, T W Mackay, D E Newby, and N J Douglas
Continuous positive airway pressure improves vascular function in obstructive sleep apnoea/hypopnoea syndrome: a randomised controlled trial
Thorax, July 1, 2008; 63(7): 578 - 583.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
F. Campos-Rodriguez, J. Perez-Ronchel, A. Grilo-Reina, J. Lima-Alvarez, M. A. Benitez, and C. Almeida-Gonzalez
Long-term Effect of Continuous Positive Airway Pressure on BP in Patients With Hypertension and Sleep Apnea
Chest, December 1, 2007; 132(6): 1847 - 1852.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
L. F. Drager, L. A. Bortolotto, A. C. Figueiredo, E. M. Krieger, and G. Lorenzi-Filho
Effects of Continuous Positive Airway Pressure on Early Signs of Atherosclerosis in Obstructive Sleep Apnea
Am. J. Respir. Crit. Care Med., October 1, 2007; 176(7): 706 - 712.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
G. Parati, C. Lombardi, and K. Narkiewicz
Sleep apnea: epidemiology, pathophysiology, and relation to cardiovascular risk
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2007; 293(4): R1671 - R1683.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
R. K. Kakkar and R. B. Berry
Positive Airway Pressure Treatment for Obstructive Sleep Apnea
Chest, September 1, 2007; 132(3): 1057 - 1072.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
U. A. Leuenberger, C. S. Hogeman, S. Quraishi, L. Linton-Frazier, and K. S. Gray
Short-term intermittent hypoxia enhances sympathetic responses to continuous hypoxia in humans
J Appl Physiol, September 1, 2007; 103(3): 835 - 842.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
J. M. Montserrat, F. Garcia-Rio, and F. Barbe
Diagnostic and Therapeutic Approach to Nonsleepy Apnea
Am. J. Respir. Crit. Care Med., July 1, 2007; 176(1): 6 - 9.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
V. A. Imadojemu, Z. Mawji, A. Kunselman, K. S. Gray, C. S. Hogeman, and U. A. Leuenberger
Sympathetic Chemoreflex Responses in Obstructive Sleep Apnea and Effects of Continuous Positive Airway Pressure Therapy
Chest, May 1, 2007; 131(5): 1406 - 1413.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
S. R. Coughlin, L. Mawdsley, J. A. Mugarza, J. P. H. Wilding, and P. M. A. Calverley
Cardiovascular and metabolic effects of CPAP in obese males with OSA
Eur. Respir. J., April 1, 2007; 29(4): 720 - 727.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
W. T. McNicholas, M. R. Bonsignore, and the Management Committee of EU COST ACTION B26
Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities
Eur. Respir. J., January 1, 2007; 29(1): 156 - 178.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
P. Coruzzi, M. Gualerzi, E. Bernkopf, L. Brambilla, V. Brambilla, V. Broia, C. Lombardi, and G. Parati
Autonomic Cardiac Modulation in Obstructive Sleep Apnea: Effect of an Oral Jaw-Positioning Appliance.
Chest, November 1, 2006; 130(5): 1362 - 1368.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
F. Campos-Rodriguez, A. Grilo-Reina, J. Perez-Ronchel, M. Merino-Sanchez, M. A. Gonzalez-Benitez, M. Beltran-Robles, and C. Almeida-Gonzalez
Effect of Continuous Positive Airway Pressure on Ambulatory BP in Patients With Sleep Apnea and Hypertension: A Placebo-Controlled Trial
Chest, June 1, 2006; 129(6): 1459 - 1467.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
G. V. Robinson, D. M. Smith, B. A. Langford, R. J. O. Davies, and J. R. Stradling
Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patients
Eur. Respir. J., June 1, 2006; 27(6): 1229 - 1235.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
A Mulgrew and J A Fleetham
How best to determine optimal nasal CPAP in patients with OSAH?
Thorax, March 1, 2006; 61(3): 186 - 187.
[Full Text] [PDF]


Home page
Eur Respir JHome page
J. Borgel, B. M. Sanner, A. Bittlinsky, F. Keskin, N. K. Bartels, N. Buechner, A. Huesing, L. C. Rump, and A. Mugge
Obstructive sleep apnoea and its therapy influence high-density lipoprotein cholesterol serum levels
Eur. Respir. J., January 1, 2006; 27(1): 121 - 127.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
P. J. Mills, B. P. Kennedy, J. S. Loredo, J. E. Dimsdale, and M. G. Ziegler
Effects of nasal continuous positive airway pressure and oxygen supplementation on norepinephrine kinetics and cardiovascular responses in obstructive sleep apnea
J Appl Physiol, January 1, 2006; 100(1): 343 - 348.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
A. R. Babu, J. Herdegen, L. Fogelfeld, S. Shott, and T. Mazzone
Type 2 Diabetes, Glycemic Control, and Continuous Positive Airway Pressure in Obstructive Sleep Apnea
Arch Intern Med, February 28, 2005; 165(4): 447 - 452.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
G V Robinson, J R Stradling, and R J O Davies
Sleep {middle dot} 6: Obstructive sleep apnoea/hypopnoea syndrome and hypertension
Thorax, December 1, 2004; 59(12): 1089 - 1094.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
E. N Simantirakis, S. I Schiza, M. E Marketou, S. I Chrysostomakis, G. I Chlouverakis, N. C Klapsinos, N. S Siafakas, and P. E Vardas
Severe bradyarrhythmias in patients with sleep apnoea: the effect of continuous positive airway pressure treatment: A long-term evaluation using an insertable loop recorder
Eur. Heart J., June 2, 2004; 25(12): 1070 - 1076.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
K. M. Oltmanns, H. Gehring, S. Rudolf, B. Schultes, S. Rook, U. Schweiger, J. Born, H. L. Fehm, and A. Peters
Hypoxia Causes Glucose Intolerance in Humans
Am. J. Respir. Crit. Care Med., June 1, 2004; 169(11): 1231 - 1237.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
O. Milleron, R. Pilliere, A. Foucher, F. de Roquefeuil, P. Aegerter, G. Jondeau, B. G Raffestin, and O. Dubourg
Benefits of obstructive sleep apnoea treatment in coronary artery disease: a long-term follow-up study
Eur. Heart J., May 1, 2004; 25(9): 728 - 734.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
S. Javaheri, W. T. Abraham, C. Brown, H. Nishiyama, R. Giesting, and L. E. Wagoner
Prevalence of obstructive sleep apnoea and periodic limb movement in 45 subjects with heart transplantation
Eur. Heart J., February 1, 2004; 25(3): 260 - 266.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
J. Heitmann, K. Ehlenz, T. Penzel, H.F. Becker, L. Grote, K.H. Voigt, J. Hermann Peter, and C. Vogelmeier
Sympathetic activity is reduced by nCPAP in hypertensive obstructive sleep apnoea patients
Eur. Respir. J., February 1, 2004; 23(2): 255 - 262.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
I. A. Harsch, S. P. Schahin, M. Radespiel-Troger, O. Weintz, H. Jahreiss, F. S. Fuchs, G. H. Wiest, E. G. Hahn, T. Lohmann, P. C. Konturek, et al.
Continuous Positive Airway Pressure Treatment Rapidly Improves Insulin Sensitivity in Patients with Obstructive Sleep Apnea Syndrome
Am. J. Respir. Crit. Care Med., January 15, 2004; 169(2): 156 - 162.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
T. Saaresranta and O. Polo
Sleep-disordered breathing and hormones
Eur. Respir. J., July 1, 2003; 22(1): 161 - 172.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
O. Marrone, A. Salvaggio, M.R. Bonsignore, G. Insalaco, and G. Bonsignore
Blood pressure responsiveness to obstructive events during sleep after chronic CPAP
Eur. Respir. J., March 1, 2003; 21(3): 509 - 514.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
R. A. Dart, J. R. Gregoire, D. D. Gutterman, and S. H. Woolf
The Association of Hypertension and Secondary Cardiovascular Disease With Sleep-Disordered Breathing
Chest, January 1, 2003; 123(1): 244 - 260.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
K. M. Hla, J. B. Skatrud, L. Finn, M. Palta, and T. Young
The Effect of Correction of Sleep-Disordered Breathing on BP in Untreated Hypertension
Chest, October 1, 2002; 122(4): 1125 - 1132.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
C. Harrington, T. Kirjavainen, A. Teng, and C. E. Sullivan
Altered Autonomic Function and Reduced Arousability in Apparent Life-Threatening Event Infants with Obstructive Sleep Apnea
Am. J. Respir. Crit. Care Med., April 15, 2002; 165(8): 1048 - 1054.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
A. Elmasry, E. Lindberg, J. Hedner, C. Janson, and G. Boman
Obstructive sleep apnoea and urine catecholamines in hypertensive males: a population-based study
Eur. Respir. J., March 1, 2002; 19(3): 511 - 517.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
J. W. H. Fung, T. S. T. Li, D. K. L. Choy, G. W. K. Yip, F. W. S. Ko, J. E. Sanderson, and D. S. C. Hui
Severe Obstructive Sleep Apnea Is Associated With Left Ventricular Diastolic Dysfunction
Chest, February 1, 2002; 121(2): 422 - 429.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
V. Belozeroff, R. B. Berry, C. S. H. Sassoon, and M. C. K. Khoo
Effects of CPAP therapy on cardiovascular variability in obstructive sleep apnea: a closed-loop analysis
Am J Physiol Heart Circ Physiol, January 1, 2002; 282(1): H110 - H121.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. S. T. LEUNG and T. DOUGLAS BRADLEY
Sleep Apnea and Cardiovascular Disease
Am. J. Respir. Crit. Care Med., December 15, 2001; 164(12): 2147 - 2165.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. C. K. KHOO, V. BELOZEROFF, R. B. BERRY, and C. S. H. SASSOON
Cardiac Autonomic Control in Obstructive Sleep Apnea . Effects of Long-term CPAP Therapy
Am. J. Respir. Crit. Care Med., September 1, 2001; 164(5): 807 - 812.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
F. Barbe, L. R. Mayoralas, J. Duran, J. F. Masa, A. Maimo, J. M. Montserrat, C. Monasterio, M. Bosch, A. Ladaria, M. Rubio, et al.
Treatment with Continuous Positive Airway Pressure Is Not Effective in Patients with Sleep Apnea but No Daytime Sleepiness: A Randomized, Controlled Trial
Ann Intern Med, June 5, 2001; 134(11): 1015 - 1023.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. M. Kaye, D. Mansfield, A. Aggarwal, M. T. Naughton, and M. D. Esler
Acute Effects of Continuous Positive Airway Pressure on Cardiac Sympathetic Tone in Congestive Heart Failure
Circulation, May 15, 2001; 103(19): 2336 - 2338.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
J. F. FACCENDA, T. W. MACKAY, N. A. BOON, and N. J. DOUGLAS
Randomized Placebo-controlled Trial of Continuous Positive Airway Pressure on Blood Pressure in the Sleep Apnea-Hypopnea Syndrome
Am. J. Respir. Crit. Care Med., February 1, 2001; 163(2): 344 - 348.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
J. Hedner and L. Grote
The Link between Sleep Apnea and Cardiovascular Disease . Time to Target the Nonsleepy Sleep Apneics?
Am. J. Respir. Crit. Care Med., January 1, 2001; 163(1): 5 - 6.
[Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
L. GROTE, H. KRAICZI, and J. HEDNER
Reduced alpha - and beta 2-Adrenergic Vascular Response in Patients with Obstructive Sleep Apnea
Am. J. Respir. Crit. Care Med., October 1, 2000; 162(4): 1480 - 1487.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. G. Phillips, M. Kato, K. Narkiewicz, I. Choe, and V. K. Somers
Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea
Am J Physiol Heart Circ Physiol, July 1, 2000; 279(1): H234 - H237.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
H. W. DUCHNA, C. GUILLEMINAULT, R. A. STOOHS, J. L. FAUL, H. MORENO, B. B. HOFFMAN, and T. F. BLASCHKE
Vascular Reactivity in Obstructive Sleep Apnea Syndrome
Am. J. Respir. Crit. Care Med., January 1, 2000; 161(1): 187 - 191.
[Abstract] [Full Text]


Home page
CirculationHome page
S. Teramoto, T. Matsuse, Y. Ouchi, K. Narkiewicz, P. van de Borne, M. E. Dyken, N. Montano, C. Cogliati, and V. K. Somers
Does the Altered Cardiovascular Variability Associated With Obstructive Sleep Apnea Contribute to Development of Cardiovascular Disease in Patients With Obstructive Sleep Apnea Syndrome? • Response
Circulation, December 21, 1999; 100 (25): e136 - e137.
[Full Text] [PDF]


Home page
CirculationHome page
K. Narkiewicz, M. Kato, B. G. Phillips, C. A. Pesek, D. E. Davison, and V. K. Somers
Nocturnal Continuous Positive Airway Pressure Decreases Daytime Sympathetic Traffic in Obstructive Sleep Apnea
Circulation, December 7, 1999; 100(23): 2332 - 2335.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
P. Lavie
Treatment of Sleep Apnea : Unmet Needs
Chest, December 1, 1999; 116(6): 1501 - 1503.
[Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
L. Chen and S. M. Scharf
Systemic and myocardial hemodynamics during periodic obstructive apneas in sedated pigs
J Appl Physiol, April 1, 1998; 84(4): 1289 - 1298.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the European Respiratory Society.